Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials - PubMed (original) (raw)
Review
Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials
Yanping Li et al. J Am Heart Assoc. 2016.
Abstract
Background: Results from observational and genetic epidemiological studies suggest that lower serum homocysteine levels are associated with lower incidence of cardiovascular disease (CVD). Numerous randomized controlled trials have investigated the efficacy of lowering homocysteine with folic acid supplementation for CVD risk, but conflicting results have been reported.
Methods and results: Three bibliographic databases (Medline, Embase, and the Cochrane Database of Systematic Reviews) were searched from database inception until December 1, 2015. Of the 1933 references reviewed for eligibility, 30 randomized controlled trials involving 82 334 participants were included in the final analysis. The pooled relative risks of folic acid supplementation compared with controls were 0.90 (95% CI 0.84-0.96; P=0.002) for stroke, 1.04 (95% CI 0.99-1.09; P=0.16) for coronary heart disease, and 0.96 (95% CI 0.92-0.99; P=0.02) for overall CVD. The intervention effects for both stroke and combined CVD were more pronounced among participants with lower plasma folate levels at baseline (both P<0.02 for interaction). In stratified analyses, a greater beneficial effect for overall CVD was seen in trials among participants without preexisting CVD (P=0.006 for interaction) or in trials with larger reduction in homocysteine levels (P=0.009 for interaction).
Conclusions: Our meta-analysis indicated a 10% lower risk of stroke and a 4% lower risk of overall CVD with folic acid supplementation. A greater benefit for CVD was observed among participants with lower plasma folate levels and without preexisting CVD and in studies with larger decreases in homocysteine levels. Folic acid supplementation had no significant effect on risk of coronary heart disease.
Keywords: cardiovascular disease prevention; folate; stroke prevention.
© 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.
Figures
Figure 1
Flow diagram of study selection process. CHD indicates coronary heart disease; CVD, cardiovascular disease; RCT, randomized controlled trial.
Figure 2
Relative risk estimates for stroke (folic acid supplementation vs control) by individual trials and pooled results. RCT indicates randomized controlled trial.
Figure 3
Relative risk estimates for coronary heart disease (folic acid supplementation vs control) by individual trials and pooled results. RCT indicates randomized controlled trial.
Figure 4
Relative risk estimates for cardiovascular diseases (folic acid supplementation vs control) by individual trials and pooled results. RCT indicates randomized controlled trial.
Figure 5
Funnel plot of data from the meta‐analysis of the effects of folic acid supplementation for preventing stroke (A), CHD (B) and CVD. CHD indicates coronary heart disease; CVD, cardiovascular disease; OR, odds ratio.
Figure 6
Relative risk of CVD in relation to percentage decreases in homocysteine concentration based on 16 trials with full records of homocysteine changes after the intervention. CVD indicates cardiovascular disease.
Similar articles
- Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels.
Miller ER 3rd, Juraschek S, Pastor-Barriuso R, Bazzano LA, Appel LJ, Guallar E. Miller ER 3rd, et al. Am J Cardiol. 2010 Aug 15;106(4):517-27. doi: 10.1016/j.amjcard.2010.03.064. Am J Cardiol. 2010. PMID: 20691310 - Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials.
Yang HT, Lee M, Hong KS, Ovbiagele B, Saver JL. Yang HT, et al. Eur J Intern Med. 2012 Dec;23(8):745-54. doi: 10.1016/j.ejim.2012.07.004. Epub 2012 Aug 11. Eur J Intern Med. 2012. PMID: 22884409 - Folic Acid Supplementation for Stroke Prevention in Patients With Cardiovascular Disease.
Tian T, Yang KQ, Cui JG, Zhou LL, Zhou XL. Tian T, et al. Am J Med Sci. 2017 Oct;354(4):379-387. doi: 10.1016/j.amjms.2017.05.020. Am J Med Sci. 2017. PMID: 29078842 Review. - Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Clarke R, Armitage J. Clarke R, et al. Semin Thromb Hemost. 2000;26(3):341-8. doi: 10.1055/s-2000-8101. Semin Thromb Hemost. 2000. PMID: 11011852 Review.
Cited by
- Daily koumiss has positive regulatory effects on blood lipids and immune system: A metabolomics study.
Wang L, Sun Y, Du L, Wang Q, Zhan M, Li S, Xiao X. Wang L, et al. Heliyon. 2024 Aug 17;10(16):e36429. doi: 10.1016/j.heliyon.2024.e36429. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39253138 Free PMC article. - Agreement Between Mega-Trials and Smaller Trials: A Systematic Review and Meta-Research Analysis.
Kastrati L, Raeisi-Dehkordi H, Llanaj E, Quezada-Pinedo HG, Khatami F, Ahanchi NS, Llane A, Meçani R, Muka T, Ioannidis JPA. Kastrati L, et al. JAMA Netw Open. 2024 Sep 3;7(9):e2432296. doi: 10.1001/jamanetworkopen.2024.32296. JAMA Netw Open. 2024. PMID: 39240561 Free PMC article. - The Antioxidant Potential of Vitamins and Their Implication in Metabolic Abnormalities.
Theodosis-Nobelos P, Rekka EA. Theodosis-Nobelos P, et al. Nutrients. 2024 Aug 16;16(16):2740. doi: 10.3390/nu16162740. Nutrients. 2024. PMID: 39203876 Free PMC article. Review. - Folic acid for the primary prevention of stroke: a systematic review and meta-analysis.
Yang J, Wang J, Li B, Zhang Y. Yang J, et al. Front Nutr. 2024 Aug 2;11:1288417. doi: 10.3389/fnut.2024.1288417. eCollection 2024. Front Nutr. 2024. PMID: 39155933 Free PMC article. - Hyperhomocysteinemia Is Associated With a Myriad of Age-Related Illnesses: A Potential Role for Metal Toxicity.
Olsen T, Refsum H, Eiser AR. Olsen T, et al. Mayo Clin Proc. 2024 Sep;99(9):1362-1368. doi: 10.1016/j.mayocp.2024.04.016. Epub 2024 Jun 26. Mayo Clin Proc. 2024. PMID: 38935017 No abstract available.
References
- Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049–1057. - PubMed
- Homocysteine and risk of ischemic heart disease and stroke: a meta‐analysis. JAMA. 2002;288:2015–2022. - PubMed
- Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from Mendelian randomisation. Lancet. 2005;365:224–232. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical